0.20Open0.20Pre Close0 Volume1 Open Interest10.00Strike Price0.00Turnover195.45%IV48.93%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier19DDays to Expiry0.20Extrinsic Value100Contract SizeAmericanOptions Type-0.0468Delta0.0113Gamma95.95Leverage Ratio-0.0214Theta-0.0005Rho-4.49Eff Leverage0.0043Vega
EverQuote Stock Discussion
• $Belite Bio (BLTE.US)$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore (ATKR.US)$ +12.11% (earnings reports)
• $AST SpaceMobile (ASTS.US)$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $Harmonic (HLIT.US)$ +7.56% (earnings reports)
• $The Chemours (CC.US)$ +7.2% ...
• $Agora (API.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $argenx SE (ARGX.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $Idacorp (IDA.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $Jakks Pacific (JAKK.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $Coca-Cola FEMSA (KOF.US)$ : Barclays Upgrades to Overweight from Equal Wei...
$EverQuote (EVER.US)$ JP Morgan reduced EverQuote, Inc. EVER price target from $41 to $17
$Triterras (TRIT.US)$ B. Riley Securities cut the price target on Triterras, Inc. TRIT from $9 to $5
No comment yet